MX2010013019A - Sales antivirales. - Google Patents
Sales antivirales.Info
- Publication number
- MX2010013019A MX2010013019A MX2010013019A MX2010013019A MX2010013019A MX 2010013019 A MX2010013019 A MX 2010013019A MX 2010013019 A MX2010013019 A MX 2010013019A MX 2010013019 A MX2010013019 A MX 2010013019A MX 2010013019 A MX2010013019 A MX 2010013019A
- Authority
- MX
- Mexico
- Prior art keywords
- salts
- treatment
- antiviral
- hrv
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Esta invención se refiere a agentes antivirales, en particular a sales útiles en el tratamiento de infecciones causadas por Picornaviridae, tal como rinovirus humano (HRV) y métodos para su preparación. La invención también se refiere al uso de estas sales en el tratamiento de infecciones por picornavirus. Las sales de esta invención son especialmente adecuadas para usarse en el tratamiento de HRV, sin embargo, se debe entender que la invención también es aplicable a otros virus de la familia picornavirus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5634108P | 2008-05-27 | 2008-05-27 | |
PCT/AU2009/000663 WO2009143571A1 (en) | 2008-05-27 | 2009-05-27 | Antiviral salts |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010013019A true MX2010013019A (es) | 2011-03-21 |
Family
ID=41376478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010013019A MX2010013019A (es) | 2008-05-27 | 2009-05-27 | Sales antivirales. |
Country Status (14)
Country | Link |
---|---|
US (2) | US8580791B2 (es) |
EP (1) | EP2297141B1 (es) |
JP (1) | JP5469662B2 (es) |
KR (1) | KR20110019759A (es) |
CN (1) | CN102046621B (es) |
AU (1) | AU2009253738B2 (es) |
BR (1) | BRPI0912038A2 (es) |
CA (1) | CA2725618C (es) |
CO (1) | CO6280534A2 (es) |
EA (1) | EA020455B1 (es) |
MX (1) | MX2010013019A (es) |
NZ (1) | NZ590286A (es) |
WO (1) | WO2009143571A1 (es) |
ZA (1) | ZA201009284B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA025224B1 (ru) * | 2010-04-15 | 2016-12-30 | Байота Сайентифик Менеджмент Пти Лтд. | ПРИМЕНЕНИЕ 3-ЭТОКСИ-6-{2-[1-(6-МЕТИЛПИРИДАЗИН-3-ИЛ)ПИПЕРИДИН-4-ИЛ]ЭТОКСИ}БЕНЗО[d]ИЗОКСАЗОЛА ИЛИ ЕГО ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМОЙ СОЛИ ПРИ ЛЕЧЕНИИ ИЛИ ОБЛЕГЧЕНИИ СИМПТОМОВ АСТМЫ |
EP2585067B1 (en) * | 2010-06-25 | 2017-08-09 | Biota Scientific Management Pty Ltd | Compound for the treatment of enteroviruses |
CN102617462B (zh) * | 2012-02-28 | 2014-02-12 | 南京大学 | 特异性抑制肌肉微小核糖核酸的化合物及其合成方法和应用 |
JP2017518325A (ja) * | 2014-06-20 | 2017-07-06 | アビラジェン セラピューティクス インコーポレイテッドAviragen Therapeutics, Inc. | 6−{2−[1−(6−メチル−3−ピリダジニル)−4−ピペリジニル]エトキシ}−3−エトキシ−1,2−ベンゾイソオキサゾールの無水結晶性遊離塩基形態 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79215B (es) | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
GB2162522B (en) | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
GB9026998D0 (en) | 1990-12-12 | 1991-01-30 | Glaxo Group Ltd | Medicaments |
US5514778A (en) * | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
AU6031898A (en) * | 1997-01-22 | 1998-08-07 | Eli Lilly And Company | Anti-viral compounds |
JP2002503253A (ja) * | 1997-06-04 | 2002-01-29 | イーライ・リリー・アンド・カンパニー | 抗ウイルス化合物 |
EP1077701A4 (en) * | 1998-05-20 | 2002-03-20 | Lilly Co Eli | ANTI-VIRAL COMPOUNDS |
US6358971B1 (en) * | 1998-05-20 | 2002-03-19 | Eli Lilly And Company | Anti-viral compounds |
AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
-
2009
- 2009-05-27 AU AU2009253738A patent/AU2009253738B2/en not_active Ceased
- 2009-05-27 CA CA2725618A patent/CA2725618C/en not_active Expired - Fee Related
- 2009-05-27 BR BRPI0912038A patent/BRPI0912038A2/pt not_active IP Right Cessation
- 2009-05-27 MX MX2010013019A patent/MX2010013019A/es active IP Right Grant
- 2009-05-27 WO PCT/AU2009/000663 patent/WO2009143571A1/en active Application Filing
- 2009-05-27 US US12/994,633 patent/US8580791B2/en active Active
- 2009-05-27 EP EP09753335.0A patent/EP2297141B1/en not_active Not-in-force
- 2009-05-27 EA EA201001835A patent/EA020455B1/ru not_active IP Right Cessation
- 2009-05-27 CN CN200980120191.2A patent/CN102046621B/zh not_active Expired - Fee Related
- 2009-05-27 KR KR1020107029303A patent/KR20110019759A/ko not_active Application Discontinuation
- 2009-05-27 NZ NZ590286A patent/NZ590286A/en not_active IP Right Cessation
- 2009-05-27 JP JP2011510782A patent/JP5469662B2/ja not_active Expired - Fee Related
-
2010
- 2010-11-25 CO CO10148308A patent/CO6280534A2/es not_active Application Discontinuation
- 2010-12-23 ZA ZA2010/09284A patent/ZA201009284B/en unknown
-
2013
- 2013-09-10 US US14/023,280 patent/US9206171B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102046621A (zh) | 2011-05-04 |
CA2725618C (en) | 2016-04-12 |
BRPI0912038A2 (pt) | 2017-06-20 |
AU2009253738B2 (en) | 2012-12-13 |
CA2725618A1 (en) | 2009-12-03 |
US20110144118A1 (en) | 2011-06-16 |
CN102046621B (zh) | 2014-11-12 |
EP2297141A1 (en) | 2011-03-23 |
EA020455B1 (ru) | 2014-11-28 |
US8580791B2 (en) | 2013-11-12 |
WO2009143571A1 (en) | 2009-12-03 |
NZ590286A (en) | 2011-08-26 |
US9206171B2 (en) | 2015-12-08 |
AU2009253738A1 (en) | 2009-12-03 |
JP2011520991A (ja) | 2011-07-21 |
EA201001835A1 (ru) | 2011-06-30 |
ZA201009284B (en) | 2012-06-27 |
EP2297141A4 (en) | 2012-04-25 |
US20140179710A1 (en) | 2014-06-26 |
CO6280534A2 (es) | 2011-05-20 |
EP2297141B1 (en) | 2015-10-21 |
JP5469662B2 (ja) | 2014-04-16 |
KR20110019759A (ko) | 2011-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
EA201100390A1 (ru) | Соединения для лечения гепатита с | |
MY170941A (en) | Pyrimidine derivatives for the treatment of viral infections | |
PH12015500274A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
UA109650C2 (xx) | Біс-арилзв'язані арилтриазолони та їх застосування | |
EA201270616A1 (ru) | Ингибиторы вируса гепатита с | |
MY173422A (en) | Purine derivatives for the treatment of viral infections | |
MX2012004032A (es) | Compuestos para el tratamiento de hepatitis c. | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
MY169159A (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
MA33806B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
MY182771A (en) | Viral replication inhibitors | |
TN2011000482A1 (en) | Organic compounds and their uses | |
PH12015502230A1 (en) | Novel viral replication inhibitors | |
EA201690964A1 (ru) | Композиции и способы для уменьшения серьезных неблагоприятных сердечно-сосудистых явлений | |
WO2013106689A8 (en) | Hcv ns3 protease inhibitors | |
MX343505B (es) | Metodos y composiciones para inhibir la transmision del vih. | |
JO3281B1 (ar) | مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي | |
MX2013004906A (es) | Nuevos inhibidores especificos de la proteasa ns3 de hcv. | |
EA201170605A1 (ru) | Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства | |
MX2010013019A (es) | Sales antivirales. | |
MA32416B1 (fr) | 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation | |
MX2010010061A (es) | Compuestos para el tratamiento de hepatitis c. | |
EA201390925A1 (ru) | Производные санглиферина и способы их получения | |
EA201590522A1 (ru) | Способы введения рифаксимина для снижения веса и лечения ожирения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |